| Breakdown | TTM | Mar 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.71B | 29.80B | 26.33B | 24.77B | 22.56B | 20.09B |
| Gross Profit | 16.93B | 14.97B | 14.82B | 9.06B | 8.68B | 11.20B |
| EBITDA | 8.63B | 8.36B | 6.54B | 5.61B | 4.90B | 4.87B |
| Net Income | 5.74B | 5.57B | 4.12B | 3.56B | 2.89B | 3.10B |
Balance Sheet | ||||||
| Total Assets | 21.49B | 19.18B | 18.31B | 19.16B | 16.19B | 13.95B |
| Cash, Cash Equivalents and Short-Term Investments | 5.92B | 4.19B | 4.73B | 4.53B | 2.89B | 1.64B |
| Total Debt | 500.00K | 500.00K | 500.00K | 500.00K | 1.20M | 1.60M |
| Total Liabilities | 9.87B | 8.95B | 8.59B | 9.27B | 7.58B | 6.06B |
| Stockholders Equity | 11.63B | 10.23B | 9.71B | 9.89B | 8.61B | 7.89B |
Cash Flow | ||||||
| Free Cash Flow | 3.77B | 3.02B | 4.42B | 3.84B | 3.45B | 3.53B |
| Operating Cash Flow | 4.22B | 3.46B | 5.09B | 4.63B | 4.62B | 4.43B |
| Investing Cash Flow | -260.00M | -435.20M | -491.50M | -666.70M | -1.12B | -793.50M |
| Financing Cash Flow | -3.65B | -3.58B | -4.40B | -2.31B | -2.25B | -4.30B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹81.26B | 30.50 | ― | 3.28% | 3.01% | 22.98% | |
70 Outperform | ₹527.64B | 43.58 | ― | 2.42% | -2.06% | -9.74% | |
64 Neutral | ₹144.71B | 65.71 | ― | 0.08% | 39.89% | 22.90% | |
64 Neutral | ₹104.88B | 14,854.71 | ― | 1.25% | -5.37% | -49.71% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ₹258.24B | 39.50 | ― | 1.39% | 7.42% | 22.99% | |
54 Neutral | ₹289.94B | 41.28 | ― | ― | 16.77% | 137.93% |
Gillette India Limited has disclosed that the Rajasthan State Pollution Control Board has refused to grant Consent to Operate for its Bhiwadi manufacturing facility and declined renewal of its authorization under Hazardous Waste Management Rules, following the company’s application for renewals. The company is assessing legal options and engaging with the state regulator, with potential implications for its manufacturing continuity and supply chain if the issues at the Bhiwadi plant are not resolved, and has committed to updating the stock exchanges on any material developments.
The refusal of environmental approvals for Gillette India’s Bhiwadi facility underscores rising regulatory scrutiny on industrial operations and compliance with pollution and hazardous waste norms. Any prolonged disruption at this site could affect production planning and may influence investor perceptions of regulatory risk, making the company’s legal and regulatory strategy critical for operational stability.